Apple simply scored an vital win in its ongoing battle with Masimo over patents associated to the Apple Watch’s blood oxygen characteristic. Listed here are the main points.
A little bit of context
Over the previous few years, Apple and well being expertise firm Masimo have been locked in a fierce authorized battle over the Apple Watch’s blood oxygen sensor.
After a number of choices and appeals, Apple needed to deactivate the expertise on Apple Watches bought within the US to keep away from a ban, and ended up creating a redesigned model of the characteristic, which moved many of the course of to the iPhone, utilizing knowledge collected by the Apple Watch.
Based on the Worldwide Commerce Fee, that was sufficient to permit Apple to renew promoting Apple Watch fashions with the characteristic enabled within the US, because the company concluded it didn’t infringe Masimo’s patents.
Naturally, Masimo disagreed and filed petitions arguing that Apple’s redesign nonetheless fell inside the scope of the prevailing exclusion order, whereas additionally difficult U.S. Customs and Border Safety’s resolution to approve the up to date watches.
This led to 2 current choices, as we lined right here:
- First, an ITC Administrative Legislation Decide Monica Bhattacharyya present in an preliminary willpower that Apple’s redesigned model of the Apple Watch’s blood oxygen characteristic doesn’t infringe Masimo’s patents.
- Second, the Federal Circuit has affirmed the ITC’s preliminary exclusion order, that means the unique model of the blood oxygen characteristic on Apple Watch continues to be banned in america.
Following these rulings, the ultimate step was for the total Fee to resolve whether or not to overview the Administrative Legislation Decide’s discovering of no infringement, which brings us to as we speak.
ITC declines overview
Earlier as we speak, the ITC declined to overview the sooner ruling as we speak, successfully closing the case and rejecting Masimo’s bid to reinstate the Apple Watch import ban.
From the choice, the place ALJ refers back to the presiding administrative legislation decide, EID refers to enforcement preliminary willpower, and LEO refers to restricted exclusion order:
On March 18, 2026, the ALJ issued the EID, which finally concluded that the accused redesigned merchandise didn’t infringe the asserted claims of the Asserted Patents. On March 25, 2026, Masimo and Apple every filed a petition for Fee overview of the EID.
On March 30, 2026, the events every filed responses to the respective petitions. The Fee has decided to not overview the EID. This mixed continuing is hereby terminated in its entirety with the conclusion that the accused redesigned merchandise don’t infringe the Asserted Patents, and subsequently, they shouldn’t be excluded pursuant to the phrases of the LEO.
In a press release to 9to5Mac, Apple mentioned:
We thank the ITC for its resolution, which ensures we will proceed to supply this vital well being characteristic to our customers. For greater than six years, Masimo has waged a relentless authorized marketing campaign in opposition to Apple, and almost all of its claims have been rejected. We’ll all the time defend our improvements, and stay centered on what we do finest: delivering the perfect services and products on the planet for our customers.
The corporate added that it’s happy to proceed providing its redesigned Blood Oxygen characteristic to customers within the US, alongside different well being options such because the ECG app and hypertension and irregular rhythm notifications.
Apple additionally emphasised the analysis and work its groups have put into creating and delivering well being, wellness, and security options on Apple Watch and throughout its different merchandise, whereas sustaining a powerful give attention to privateness.
Masimo can nonetheless enchantment the choice.
You’ll be able to learn the ITC’s full resolution from as we speak beneath:
Value trying out on Amazon
FTC: We use revenue incomes auto affiliate hyperlinks. Extra.
